Product Technology Overview: JOBST® Comprifore
October 8, 2014
By Chinenye Queen Ezike and James McGuire DPM, PT, CPed, FAPWHc
Venous Leg Ulcers (VLUs) are the most common cause of lower extremity ulcerations, affecting about 1% of the US population. Recurrenc...
RedDress Launches ActiGraft PRO with G-Code Reimbursement Status
July 20, 2023
TEL AVIV, Israel and JACKSONVILLE, FL - (July 18, 2023) ActiGraft PRO is now commercially available in the US and eligible for reimbursement from Medicare and Medicare Advantage via NCD 270.3 and G-0465 & G-0460 codes. Medicare and Medicare Advantage plans will now reimburse $1,726 per application for up to 20 applications. This eligibility applies to diabetic foot ulcer (DFU) treatment.
Vibrio vulnificus: What Are the Risks
September 15, 2023
On September 1, the Centers for Disease Control and Prevention (CDC) issued a health advisory regarding the pathogen Vibrio vulnificus. V. vulnificus is a rare but aggressive species of Vibrio bacteri...
What Wound Care Advocacy Achieved in 2023 and Works Toward in 2024
February 23, 2024
The wound care community had an exciting and impactful 2023 on the advocacy front. The power of collaborative action and a collective voice resulted in two major advocacy successes, advocated by the Alliance of Wound Care Stakeholders, protecting patient access to key wound care services.
